This week’s topics include the safety and efficacy of sitagliptin for type 2 diabetes, use of glucocorticoids and the risk of VTE, and forced smoking abstinence.
This is why we hold conferences — to share in the value of research and to promote enthusiasm to continue with new endeavors.
This week’s topics include the ADVANCE III trial, the latest fish-oil supplement study, and a review of management strategies for asymptomatic carotid stenosis.
Looking back at the knowledge gained and friendships kindled at HRS 2013, this Fellow looks forward to HRS 2014.
I finally managed to walk to the Fellows in Training lounge, hoping to connect with some co-fellows. I did find lot of fellows, but to my surprise Dr. Zipes was there and ready to answer burning questions about getting published.
In recent weeks the cardiac resynchronization therapy (CRT) field has been absorbing the publication of the BLOCK HF trial in the New England Journal of Medicine and the publication of the NARROW-CRT trial in Circulation: Arrhythmia and Electrophysiology. These trials raised the possibility that CRT may improve clinical status in some patients with ischemic cardiomyopathy…
HRS yields useful insights, both personal and professional.
An emotion-raising debate, a late-breaker session, and technological innovations focus this fellow, despite Denver’s many attractions.
A fellow experiences one exceptional presentation after another at the first day of HRS 2013.
My 3-year-old daughter helps me see the influence of pharma on research.